Drug intelligence / Profile preview

BiSKIT

Development stage
Unknown
Lead developer
Medicenna Therapeutics
Modality
Small Molecules
Administration
Oral
01

Overview

BiSKIT is a combination antibiotic and antifungal medication developed by Chicky Pharma Pvt. Ltd. for the syndromic management of vaginal discharge and infections. It contains three active ingredients: azithromycin (1000 mg), a macrolide antibiotic that inhibits bacterial protein synthesis; fluconazole (150 mg), an antifungal agent; and secnidazole (2000 mg), a nitroimidazole antibiotic and antiprotozoal. This combination therapy is designed to treat a broad spectrum of pathogens simultaneously, including those responsible for bacterial vaginosis, vulvovaginal candidiasis, trichomoniasis, and mixed infections involving *Chlamydia trachomatis* and *Neisseria gonorrhoeae*. It is typically administered as a single-dose oral regimen.

Brand names
BiSKIT
02

Targets

IL-2R (Interleukin-2/interleukin-15 receptor complex)PDCD1 (Programmed cell death protein 1 receptor)

Beyond the preview

Go deeper on BiSKIT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BiSKIT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call